BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Eadens MJ, Grothey A. Curable metastatic colorectal cancer. Curr Oncol Rep. 2011;13:168-176. [PMID: 21298372 DOI: 10.1007/s11912-011-0157-0] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 2.9] [Reference Citation Analysis]
Number Citing Articles
1 Chang L, Zhou D, Luo S. Novel lncRNA LINC00941 Promotes Proliferation and Invasion of Colon Cancer Through Activation of MYC. Onco Targets Ther 2021;14:1173-86. [PMID: 33654409 DOI: 10.2147/OTT.S293519] [Reference Citation Analysis]
2 Lai H, Wei JC, Hung H, Lin C. Impact of treatment modality on clinical outcome in metastatic colorectal cancer patients stratified by metastatic sites. Postgraduate Medicine 2019;131:163-70. [DOI: 10.1080/00325481.2019.1568016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Ferguson J, Alzahrani N, Zhao J, Glenn D, Power M, Liauw W, Morris D. Long term results of RFA to lung metastases from colorectal cancer in 157 patients. European Journal of Surgical Oncology (EJSO) 2015;41:690-5. [DOI: 10.1016/j.ejso.2015.01.024] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
4 Rajakannu M, Magdeleinat P, Vibert E, Ciacio O, Pittau G, Innominato P, Sacunha A, Cherqui D, Morère J, Castaing D, Adam R. Is Cure Possible After Sequential Resection of Hepatic and Pulmonary Metastases From Colorectal Cancer? Clinical Colorectal Cancer 2018;17:41-9. [DOI: 10.1016/j.clcc.2017.06.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
5 Vandeputte C, Bregni G, Gkolfakis P, Guiot T, Pretta A, Kehagias P, Senti C, Reina EA, Van Bogaert C, Deleporte A, Geboes K, Delaunoit T, Demolin G, Peeters M, D'Hondt L, Janssens J, Carrasco J, Holbrechts S, Goeminne JC, Vergauwe P, Van Laethem JL, Flamen P, Hendlisz A, Sclafani F. Sex and Regorafenib Toxicity in Refractory Colorectal Cancer: Safety Analysis of the RegARd-C Trial. Clin Colorectal Cancer 2021:S1533-0028(21)00071-2. [PMID: 34404621 DOI: 10.1016/j.clcc.2021.07.006] [Reference Citation Analysis]
6 Lewis MA, Hobday TJ. Treatment of neuroendocrine tumor liver metastases. Int J Hepatol 2012;2012:973946. [PMID: 23227348 DOI: 10.1155/2012/973946] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
7 Liu Q, Shan Z, Luo D, Cai S, Li Q, Li X. Palliative beam radiotherapy offered real-world survival benefit to metastatic rectal cancer: A large US population-based and propensity score-matched study. J Cancer 2019;10:1216-25. [PMID: 30854131 DOI: 10.7150/jca.28768] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Liu K, Wan J, Zhu J, Li G, Sun W, Shen L, Cai S, Gu W, Lian P, Zhang Z. Role of pelvic radiotherapy for locally advanced rectal cancer and synchronous unresectable distant metastases. Cancer/Radiothérapie 2016;20:805-10. [DOI: 10.1016/j.canrad.2016.06.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
9 Dumitrascu T, Ionescu M. Long-term survival in a case of malignant familial adenomatous polyposis coli with metachronous liver, lung and brain metastases: Long-term survival in a case of malignant familial adenomatous polyposis coli. Colorectal Disease 2012;14:e74-5. [DOI: 10.1111/j.1463-1318.2011.02627.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
10 Kim YS, Shin JH, Bae MK, Lee CY, Kim DJ, Chung KY, Lee JG. Autophagy activity in pulmonary metastatic tumor tissues from colorectal cancer: a pilot study. Yonsei Med J 2014;55:1484-8. [PMID: 25323883 DOI: 10.3349/ymj.2014.55.6.1484] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
11 Lewis MA, Hubbard J. Multimodal liver-directed management of neuroendocrine hepatic metastases. Int J Hepatol. 2011;2011:452343. [PMID: 22121491 DOI: 10.4061/2011/452343] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
12 Agolli L, Nicosia L. Recent prospective data regarding good survival outcome after radiofrequency ablation of lung metastases from colorectal cancer: the radiation oncologist point of view. Quant Imaging Med Surg 2020;10:1182-5. [PMID: 32489944 DOI: 10.21037/qims-2020-13] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Lei C, Zhao B, Liu L, Zeng X, Yu Z, Wang X. Expression and clinical significance of p62 protein in colon cancer. Medicine (Baltimore) 2020;99:e18791. [PMID: 32011477 DOI: 10.1097/MD.0000000000018791] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
14 Cheung TT, Poon RTP. Synchronous resections of primary colorectal tumor and liver metastasis by laparoscopic approach. World J Hepatol 2013; 5(6): 298-301 [PMID: 23805353 DOI: 10.4254/wjh.v5.i6.298] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
15 Yang L, Yang X, He W, Liu S, Jiang C, Xie K, Peng K, You Y, Zhang B, Xia L. Comparisons of metastatic patterns of colorectal cancer among patients by age group: a population-based study. Aging (Albany NY) 2018;10:4107-19. [PMID: 30594909 DOI: 10.18632/aging.101700] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
16 Liu K, Jin M, Ye S, Yan S. CHI3L1 promotes proliferation and improves sensitivity to cetuximab in colon cancer cells by down-regulating p53. J Clin Lab Anal 2020;34:e23026. [PMID: 31536166 DOI: 10.1002/jcla.23026] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
17 Sourrouille I, Mordant P, Maggiori L, Dokmak S, Lesèche G, Panis Y, Belghiti J, Castier Y. Long-term survival after hepatic and pulmonary resection of colorectal cancer metastases. J Surg Oncol. 2013;108:220-224. [PMID: 23893480 DOI: 10.1002/jso.23385] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
18 Kim DY, Paek TY, Oh SY, Kim YB, Lee JH, Lee MY, Choi ZS, Suh KW. Pretreatment selection of regimen according to genetic analysis improves the efficacy of chemotherapy in the first line treatment of metastatic colorectal cancer. J Surg Oncol 2014;109:250-4. [PMID: 24318863 DOI: 10.1002/jso.23500] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
19 Husson O, Thong MS, Mols F, Smilde TJ, Creemers GJ, van de Poll-Franse LV. Information provision and patient reported outcomes in patients with metastasized colorectal cancer: results from the PROFILES registry. J Palliat Med 2013;16:281-8. [PMID: 23437833 DOI: 10.1089/jpm.2012.0430] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
20 Liao W, Li G, You Y, Wan H, Wu Q, Wang C, Lv N. Antitumor activity of Notch‑1 inhibition in human colorectal carcinoma cells. Oncol Rep 2018;39:1063-71. [PMID: 29286145 DOI: 10.3892/or.2017.6176] [Cited by in Crossref: 3] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
21 Cheung TT, Poon RTP, Yuen WK, Chok KSH, Tsang SHY, Yau T, Chan SC, Lo CM. Outcome of laparoscopic versus open hepatectomy for colorectal liver metastases: Laparoscopic versus open hepatectomy. ANZ J Surg 2013;83:847-52. [DOI: 10.1111/j.1445-2197.2012.06270.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 4.3] [Reference Citation Analysis]
22 Shimomura M, Okajima M, Hinoi T, Egi H, Takakura Y, Kawaguchi Y, Tokunaga M, Adachi T, Tashiro H, Ohdan H. Identification of patients likely to benefit from metastasectomy in stage IV colorectal cancer. Int J Colorectal Dis 2012;27:1339-46. [DOI: 10.1007/s00384-012-1454-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
23 Tseng WW, Gronchi A. Surgery for recurrence in retroperitoneal leiomyosarcoma: Is it all about selection? J Surg Oncol 2017;116:267-8. [DOI: 10.1002/jso.24745] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
24 Chang HHL, Leeper WR, Chan G, Quan D, Driman DK. Infarct-like Necrosis: A Distinct Form of Necrosis Seen in Colorectal Carcinoma Liver Metastases Treated With Perioperative Chemotherapy. American Journal of Surgical Pathology 2012;36:570-6. [DOI: 10.1097/pas.0b013e31824057e7] [Cited by in Crossref: 41] [Cited by in F6Publishing: 22] [Article Influence: 4.6] [Reference Citation Analysis]
25 Wang X, Zamdborg L, Ye H, Grills IS, Yan D. A matched-pair analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lung tumors from colorectal cancer versus early stage non-small cell lung cancer. BMC Cancer 2018;18:962. [PMID: 30305131 DOI: 10.1186/s12885-018-4865-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
26 Logan JK, Huber KE, Dipetrillo TA, Wazer DE, Leonard KL. Patterns of care of radiation therapy in patients with stage IV rectal cancer: a Surveillance, Epidemiology, and End Results analysis of patients from 2004 to 2009. Cancer 2014;120:731-7. [PMID: 24227451 DOI: 10.1002/cncr.28467] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]